---
title: "ProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278990351.md"
description: "ProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty"
datetime: "2026-03-13T06:01:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278990351.md)
  - [en](https://longbridge.com/en/news/278990351.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278990351.md)
---

# ProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty

ProQR Therapeutics Faces Heightened Activist Investor Pressure and Governance Uncertainty

### Related Stocks

- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [PRQR.US](https://longbridge.com/en/quote/PRQR.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)

## Related News & Research

- [Avant Brands Reports Q1 2026 Results Highlighted by 37% Growth in Recreational Revenue | AVTBF Stock News](https://longbridge.com/en/news/282741678.md)
- [Revolution Medicines' experimental cancer pill helps improve survival in late-stage study](https://longbridge.com/en/news/282540793.md)
- [Pancreatic cancer pill shown to nearly double overall survival time, drug company says](https://longbridge.com/en/news/282687539.md)
- [Arcutis Biotherapeutics Targets ZORYVE Expansion, Raises 2026 Outlook and Turns Cash-Flow Positive](https://longbridge.com/en/news/282775123.md)
- [BUZZ-Allogene tumbles on $175 mln stock offering after cancer therapy data](https://longbridge.com/en/news/282722450.md)